CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fulcrum Pharma plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fulcrum Pharma plc
5th Floor, Kodak House
Station Road
Phone: (1442) 283-600p:1442 283-600 Hertfordshire, ENG  HP1 1JY  United Kingdom Ticker: FULFUL
This company is no longer actively traded on any major stock exchange.
Business Summary
Fulcrum Pharma plc is a United Kingdom-based company. The Company is engaged in providing solutions for the development of therapeutic products. It provides regulatory expertise and resource throughout all stages of product development. The Company provides customized pharmacovigilance and risk management solutions. It provides support for product registration, launch and in market maintenance. It operates through eight offices across the United States, Europe and Japan. The Company’s subsidiaries include Fulcrum Pharma (Europe) Limited, Fulcrum Pharma Developments Limited, Quadramed Limited, Unicus Limited and Fulcrum Regulatory Limited.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/20108/31/2009Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Grahame D.Cook 52 8/28/2008 8/28/2008
Chief Executive Officer, Executive Director Frank M.Armstrong 52 4/1/2008 4/1/2008
Chief Financial Officer, Executive Director Barry K.Knight 55 6/8/2009 6/8/2009
11 additional Officers and Directors records available in full report.

Business Names
Business Name
FUL
Fulcrum Pharma (Europe) Limited
Fulcrum Pharma Developments Limited
4 additional Business Names available in full report.

General Information
Number of Employees: 145 (As of 8/31/2009)
Outstanding Shares: 177,940,743 (As of 11/19/2009)
Shareholders: 15,627
Stock Exchange: SEA
Fax Number: (1442) 283-613


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023